Delivery Order SPE2DB20D2104-SPE2DB23FV03H
- Not listed
- This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMADY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,791.27 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 10, 2024 and was awarded on October 9, 2024. This award is not designated as a set-aside contract....
- This federal contract award, with ID SPE2DB22D3019|SPE2DB25FK3FB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.54 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,288.17 fixed-price delivery order is for the medication MOVANTIK 25 MG TABLET 30S. The contract has an ultimate completion date of April 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the vendor holds with the DLA Troop Support Medical, which provides a comprehensive range...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,017.58 for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a completion date of February 24, 2025 and is a Firm Fixed Price arrangement. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract is a Delivery Order with a Firm Fixed Price of $1,405.17 and a period of performance through February 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,373.23, is for the delivery of MOVANTIK 25 MG TABLET 30S medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp (DUNS: KABZK8W6PQT3) is a Firm Fixed Price Delivery Order worth $9,105.05, awarded by the Defense Logistics Agency (DLA). The contract is for the provision of MOVANTIK 12.5 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 27, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite...
- This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4564703549 - MOVANTIK 25 MG TABLET UD 100S. The contract has a firm fixed price ceiling value of $3,758.36 and a period of performance through May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Movantik 25 mg tablets in unit dose packaging (100 count). This contract, valued at $9,764.64 with a firm fixed price structure, was competitively awarded without set-aside designation and is scheduled for completion by January 5, 2026. The award was issued on January 2, 2026, with performance taking place at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV03HDelivery Order
This federal contract award, identified as SPE2DB20D2104|SPE2DB23FV03H, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,622.16 fixed-price delivery order is for the supply of 4561934977 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 25, 2023 and was awarded on August 24, 2023. It does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/24/23 |